Rabelink TJ - Search Results

1

Progenitor cells in the kidney: biology and therapeutic perspectives.

Rookmaaker MB, Verhaar MC, van Zonneveld AJ, Rabelink TJ. Rookmaaker MB, et al. Among authors: rabelink tj. Kidney Int. 2004 Aug;66(2):518-22. doi: 10.1111/j.1523-1755.2004.761_10.x. Kidney Int. 2004. PMID: 15253701 Free article. Review.

2

Early and late adjustment to potassium loading in humans.

Rabelink TJ, Koomans HA, Hené RJ, Dorhout Mees EJ. Rabelink TJ, et al. Kidney Int. 1990 Nov;38(5):942-7. doi: 10.1038/ki.1990.295. Kidney Int. 1990. PMID: 2266680 Free article.

3

Naloxone inhibits renal hemodynamic effect of head-out water immersion in humans.

Van Tilborg KA, Rabelink TJ, Koomans HA. Van Tilborg KA, et al. Among authors: rabelink tj. Kidney Int. 1995 Sep;48(3):860-5. doi: 10.1038/ki.1995.362. Kidney Int. 1995. PMID: 7474676 Free article. Clinical Trial.

4

Thrombosis and hemostasis in renal disease.

Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Rabelink TJ, et al. Kidney Int. 1994 Aug;46(2):287-96. doi: 10.1038/ki.1994.274. Kidney Int. 1994. PMID: 7967339 Free article. Review. No abstract available.

5

Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology.

Rabelink TJ, Kaasjager KA, Boer P, Stroes EG, Braam B, Koomans HA. Rabelink TJ, et al. Kidney Int. 1994 Aug;46(2):376-81. doi: 10.1038/ki.1994.284. Kidney Int. 1994. PMID: 7967349 Free article. Clinical Trial.

6

Endothelin in renal pathophysiology: from experimental to therapeutic application.

Rabelink TJ, Kaasjager KA, Stroes ES, Koomans HA. Rabelink TJ, et al. Kidney Int. 1996 Dec;50(6):1827-33. doi: 10.1038/ki.1996.502. Kidney Int. 1996. PMID: 8943463 Free article. Review. No abstract available.

7

Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes.

de Sain-van der Velden MG, Kaysen GA, de Meer K, Stellaard F, Voorbij HA, Reijngoud DJ, Rabelink TJ, Koomans HA. de Sain-van der Velden MG, et al. Among authors: rabelink tj. Kidney Int. 1998 Jan;53(1):181-8. doi: 10.1046/j.1523-1755.1998.00729.x. Kidney Int. 1998. PMID: 9453016 Free article.

8

5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.

Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA, Rabelink TJ. Verhaar MC, et al. Among authors: rabelink tj. Circulation. 1998 Jan 27;97(3):237-41. doi: 10.1161/01.cir.97.3.237. Circulation. 1998. PMID: 9462523 Clinical Trial.

9

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. Verhaar MC, et al. Among authors: rabelink tj. Circulation. 1998 Mar 3;97(8):752-6. doi: 10.1161/01.cir.97.8.752. Circulation. 1998. PMID: 9498538

10

Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.

Verhaar MC, Beutler JJ, Gaillard CA, Koomans HA, Fijnheer R, Rabelink TJ. Verhaar MC, et al. Among authors: rabelink tj. J Hypertens. 1998 Jan;16(1):45-50. doi: 10.1097/00004872-199816010-00008. J Hypertens. 1998. PMID: 9533416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters